Articles From: Altria Reports 2014 Second-Quarter and First-Half Results; Revises Full-Year EPS Guidance; and Announces New $1 Billion Share Repurchase Program to Amaya receives gaming regulatory approvals for Rational Group acquisition


2014/7/22
Altria Group, Inc. (Altria) (NYSE:MO) today announced its 2014 second-quarter and first-half business results.
Sign-up for Altria Reports 2014 Second-Quarter and First-Half Results; Revises Full-Year EPS Guidance; and Announces New $1 Billion Share Repurchase Program investment picks
2014/8/20
Altria Group, Inc. (Altria) (NYSE:MO) will host a webcast of its business presentation at the Barclays Back-To-School Consumer Conference in Boston, Mass., on Wednesday, September 3, 2014, at approximately 12:45 p.m. Eastern Time.
Sign-up for Altria to Host Webcast from the Barclays Back-To-School Consumer Conference investment picks
2014/7/8
Altria Group, Inc. (Altria) (NYSE:MO) will host a live audio webcast on Tuesday, July 22, 2014 at 9:00 a.m. Eastern Time to discuss its 2014 second-quarter business results.
Sign-up for Altria to Host Webcast of 2014 Second-Quarter Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0959691001&sourceType=1 http://www.ccnmatthews.com/logos/20110608-altus200.jpg TORONTO, ONTARIO --
Sign-up for Altus Group Completes Early Redemption of 5.75% Convertible Debentures investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0968786001&sourceType=1 http://www.ccnmatthews.com/logos/20110608-altus200.jpg TORONTO, ONTARIO --
Sign-up for Altus Group Limited Announces Third Quarter Dividend investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961303001&sourceType=1 http://www.ccnmatthews.com/logos/20110608-altus200.jpg TORONTO, ONTARIO --
Sign-up for Altus Group Reports Second Quarter Financial Results for 2014 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0958816001&sourceType=1 http://www.ccnmatthews.com/logos/20110608-altus200.jpg TORONTO, ONTARIO --
Sign-up for Altus Group Strengthens its Data and Market Research Offering Through Acquisition of RealNet investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961331001&sourceType=1 http://www.ccnmatthews.com/logos/20110608-altus200.jpg TORONTO, ONTARIO --
Sign-up for Altus Group Welcomes Janet Graham to Board of Directors investment picks
COLUMBUS, Ohio , July 22, 2014 /PRNewswire/ -- DSW Inc. (NYSE: DSW) , the leading branded footwear and accessories retailer, has announced its winner in its Shoe Lovers Care Leave Your Mark program: the Alzheimer's Association , based in Chicago, IL.
Sign-up for Alzheimer's Association Voted Winner of $75,000 Donation from DSW investment picks
WALTHAM, Mass., Sept.
Sign-up for AMAG Pharmaceuticals Announces Appointment of John A. Fallon, M.D. to Board of Directors investment picks
Record Physician Demand Drives 27% Increase in U.S. Net Feraheme Revenues WALTHAM, Mass., July 29, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) , a specialty pharmaceutical company, today reported unaudited consolidated financial results for the quarter and six months ended June 30, 2014.
Sign-up for AMAG Pharmaceuticals Announces Second Quarter and Six Month 2014 Financial Results and Updates Financial Guidance for 2014 investment picks
LEXINGTON, Mass., July 25, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced it will report unaudited consolidated financial results for the quarter and six months ended June 30, 2014 before the U.S. financial markets open on Tuesday, July 29, 2014.
Sign-up for AMAG Pharmaceuticals, Inc. to Host Conference Call on July 29, 2014 at 8:00 a.m. ET to Discuss Financial Results for the Quarter and Six Months Ended June 30, 2014 investment picks
WALTHAM, Mass., Aug.
Sign-up for AMAG Pharmaceuticals, Inc. to Participate in Jefferies Boston Healthcare Summit investment picks
WALTHAM, Mass., Aug.
Sign-up for AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences investment picks
SAN FRANCISCO, July 7, 2014 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCBB:AMBS) , a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration and apoptosis, today announced that Gerald Commissiong, President and CEO will host and participate in a Twitter chat on Thursday, July 10, 2014 from 4-4:30pm EDT via his Twitter handle @G_Commish .
Sign-up for Amarantus' CEO to Host Twitter Chat on Thursday, July 10, 2014 at 4pm EDT investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G021607-001&sourceType=1 BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - September 12, 2014) - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that the Office of New Drugs (OND) within the U.S. Food and Drug Administration (FDA) has denied Amarin's appeal of FDA's rescission of the ANCHOR clinical trial Special Protocol Assessment (SPA) agreement.
Sign-up for Amarin Provides Update on ANCHOR Trial SPA Agreement Rescission Appeal investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G021800-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/9/15/11G021800/amarin-1279518830220.jpg BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - September 16, 2014) - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today its continued commitment to completing the ongoing REDUCE-IT (Reduction of Cardiovascular Events with EPA - Intervention Trial) cardiovascular outcomes study.
Sign-up for Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G019654-001&sourceType=1 BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - August 07, 2014) - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced financial results for the quarter and six months ended June 30, 2014, and provided an update on company operations.
Sign-up for Amarin Reports Second Quarter 2014 Financial Results and Provides Update on Operations investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G020932-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/9/2/11G020932/logo-1384140982526.jpg BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - September 03, 2014) - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F.
Sign-up for Amarin to Present at the Rodman & Renshaw 2014 Global Investment Conference investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G019528-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/8/4/11G019528/amarin-1011300204880.jpg BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - August 05, 2014) - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced that it will host a conference call with members of Amarin senior management to discuss the company's second quarter 2014 financial results and provide an operational update on Thursday, August 7, at 4:30 p.m. ET.
Sign-up for Amarin to Report Second Quarter 2014 Results and Host Conference Call on August 7, 2014 investment picks
LAS VEGAS , July 29, 2014 /PRNewswire/ -- Amarium Technologies, Inc. (OTC: AMMG) through its wholly owned subsidiary Amarium Minerals Inc., reports that the Company has signed a definitive agreement to acquire the El Desvan Cobre SA property, located in Michoacan , Mexico.
Sign-up for Amarium Acquires Additional Production at El Desvan Cobre investment picks
LAS VEGAS , July 8, 2014 /PRNewswire/ -- Amarium Technologies Inc. (OTC: AMMG) (PINKSHEETS: AMMG), through its wholly owned subsidiary Amarium Minerals, is pleased to announce completion of upgrades to their ore processing mill located at the San Pedro Mine.
Sign-up for Amarium Announces 600% Increase in Production Capacity at San Pedro investment picks
LAS VEGAS , July 1, 2014 /PRNewswire/ -- Amarium Technologies Inc. (OTC: AMMG) through its wholly owned subsidiary Amarium Minerals Inc., announces it has received preliminary earnings and production results along with improved operational efficiency for the 2 nd Quarter of 2014 ending June 30 .
Sign-up for Amarium Announces Earnings, Production and Improvements to Operational Efficiency for 2014 Q2 investment picks
2014/7/10
LAS VEGAS , July 10, 2014 /PRNewswire/ -- Amarium Technologies, Inc. (PINKSHEETS: AMMG) through it's wholly owned subsidiary Amarium Minerals Inc., reports the appointment of Mr.
Sign-up for Amarium Appoints Career Miner as Manager of Operations at San Pedro investment picks
LAS VEGAS , Aug.
Sign-up for Amarium Begins Ore Extraction at El Desvan Cobre investment picks
MONTREAL , July 7, 2014 /PRNewswire/ - Amaya Gaming Group Inc. (TSX: AYA) (" Amaya " or the " Corporation ") announced today the completion of its previously announced offering, on an underwritten bought-deal private-placement basis, of 25 million subscription receipts priced at $20 per subscription receipt (the " Subscription Receipts "), and that the underwriters of the offering have exercised in full the option granted to them to purchase an additional seven million Subscription Receipts (the " Subscription Receipt Offering "). Total gross proceeds to Amaya from the Subscription Receipt Offering are $640 million .
Sign-up for Amaya announces closing of Subscription Receipt Offering including exercise of Underwriters' option for gross proceeds of $640 million investment picks
Splunk Inc. (NASDAQ: SPLK), provider of the leading software platform for real-time Operational Intelligence, today announced that Amaya Gaming , provider of a full suite of online gaming products and services, has transformed its development approach and enhanced performance across its online properties with the help of Splunk® Enterprise.
Sign-up for Amaya Gaming Gains Operational Intelligence Across its Global Websites with Splunk Software investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Altria Reports 2014 Second-Quarter and First-Half Results; Revises Full-Year EPS Guidance; and Announces New $1 Billion Share Repurchase Program to Amaya receives gaming regulatory approvals for Rational Group acquisition
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices